A new AI-derived tumor marker can enhance treatment response assessment in pancreatic cancer patients who do not produce elevated CA19-9. In a study of 121 patients, a 50% or more decline in the marker (e19-9) was linked to a 5-fold higher likelihood of completing neoadjuvant therapy and surgery. An e19-9 level below 100 significantly correlated […]

Many gallbladder cancer patients thought to be node-negative actually show hidden nodal metastasis, impacting surgical outcomes. Of 187 patients, 33.1% classified as clinically node-negative had occult nodal disease upon final pathology. Key preoperative predictors included elevated CA19-9, systemic immune-inflammation index, and jaundice. Risk of occult nodal disease increases significantly with more elevated markers: from 17.1% […]

Converting minimally invasive liver surgery may significantly impact patient outcomes based on urgency and approach. Among 10,548 cases, 6.8% required conversion, with emergency conversions linked to increased blood loss, transfusions, and severe morbidity. Elective conversions showed a safer profile, while robotic conversion had a concerning 7.7% mortality rate. Understanding these factors is vital for surgical […]

Radiological adjacent organ invasion in resectable left-sided pancreatic cancer indicates worse prognosis and may alter treatment strategies. Patients with adjacent organ invasion had median survival of 25.9 months versus 67.2 months for those without (p < 0.001). Elevated CA19-9 levels (≥279 U/ml) and positive peritoneal cytology were significantly more common in the invasion group. Consider […]

Minimally invasive surgery (MIS) lowers surgical risks in both initial and repeat hepatectomies, crucial for improving patient outcomes. In initial hepatectomy patients, MIS is linked to a lower risk of postoperative morbidity. For repeat hepatectomies, each point increase in adhesion severity (TORAD v2.0) raises morbidity risk by 60%, while MIS reduces this risk significantly (odds […]

High tissue factor (tf) expression in pancreatic cancer correlates with worse outcomes, offering a vital tool for patient selection. High tf was noted in 17.4% of cases, linked to elevated CA19-9 and shorter survival (median: 20.6 months vs. 38.8 months in low tf). It served as an independent poor prognosis predictor (hazard ratio: 2.21). Surgeons […]

Surgeons need to know that elevated vasopressin significantly contributes to fluid retention after liver resection, impacting postoperative management. Vasopressin (AVP) levels peaked immediately after major liver resections and stayed elevated through postoperative day 3, while aldosterone levels dropped by postoperative day 2. Patients showed greater short-term weight gain and decreased urine output during the AVP […]

A new CT-based analysis effectively predicts early recurrence in hepatocellular carcinoma, offering surgeons a powerful tool for patient stratification. The nested habitats score achieved area under the curve values of 0.832, 0.896, and 0.833 across three cohorts, indicating strong predictive power. It remains an independent predictor of recurrence-free survival alongside other known factors like alkaline […]

Percutaneous transhepatic cholangioscopy (PTCS) is effective for treating postoperative benign bilioenteric strictures and biliary stones. Initial anastomotic patency rates are 58.1% at 1 year and 41.9% at 2 years. Cumulative patency rates drop to 34.8% after 7 years but treatment success is high at 90.6%. These findings suggest PTCS should be a go-to for managing […]